Journal
Blood Advances
Publication Date
7-22-2025
Volume
9
Issue
14
First Page
3479
Last Page
3494
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2025016170
Rights and Permissions
Sharma R, Holtzman NG, Pusic I, Cutler C, Treister N, Mehta RS, Alousi AS, Vigneswaran N, Javaid A, Boksa F, Mody DP, Costa-da-Silva AC, Schueller O, Macé S, Yao Y, Ji R, Hu B, Marshall K, Blazar BR, Lee SJ, Pavletic SZ, Mays JW. Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study. Blood Adv. 2025 Jul 22;9(14):3479-3494. doi: 10.1182/bloodadvances.2025016170. © 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Sharma, Rubina; Pusic, Iskra; and et al., "Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: A ROCKstar companion study." Blood Advances. 9, 14. 3479 - 3494. (2025).
https://digitalcommons.wustl.edu/oa_4/5898
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
